51¥

The 51¥ Journal

For high-quality, full-length papers and expert reviews relevant to the molecular, cellular and biochemical life sciences.

Editor-in-Chief: Seamus Martin

Key Features: Diverse and engaging | Most accepted manuscripts undergo only one round of revision | Free to publish (no page charges) or choose options

Key Metrics 2022: Impact Factor 5.4 | CiteScore 10.1 | Cited Half-life 8.7 years | Median time from submission to first decision after peer review: 38 days

Award: is awarded annually to authors of an outstanding paper published in the previous calendar year.



51¥ Letters

For rapid publication of research reports that significantly impact and advance knowledge, and timely reviews of wide interest in the molecular biosciences.

Editor-in-Chief: Michael Brunner

Key Features: primary research and review article formats |  builds bridges between science and society | Free to publish (no page charges) or choose options

Key Metrics 2022: Impact Factor 3.5 | CiteScore 7.0 | Cited Half-life 16.8 years | Median time from submission to first decision after peer review: 22 days

Award: is given annually to the senior author of an outstanding paper published in 51¥ Letters during the previous year.



51¥ Open Bio

For publication of research articles in the molecular and cellular life sciences, with the emphasis on technical and ethical quality rather than objective judgements of significance. Research articles on Education in the molecular life sciences are published free of charge.

Editor-in-Chief: Miguel De la Rosa

Key Features: free to publish | with the annual 51¥ Congress | 

Key Metrics 2022: Impact Factor 2.6 | CiteScore 4.7 | Cited Half-life 3.7 years | Median time from submission to first decision after peer review: 33 days

Award:  is awarded to an early career researcher who has published an outstanding paper in the previous calendar year.



Molecular Oncology

For high-impact research articles in basic, translational and clinical cancer research, and reviews and policy papers discussing emerging concepts in cancer research, cancer diagnosis, prevention and care.

Editor-in-Chief: Kevin Ryan

Key Features: Focus on basic, translational, or clinical cancer research, and cancer policy |

Key Metrics 2022: Impact Factor 6.6 | CiteScore 11.8 | Cited Half-life 4.5 years | Median time from submission to first decision after peer review: 41 days